Log In
Print
BCIQ
Print
Print this Print this
 

BeneFIX

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionRecombinant coagulation Factor IX (rFIX)
Molecular Target Factor IX
Mechanism of ActionFactor IX replacement
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationHemophilia
Indication DetailsContinuous prophylactic treatment of bleeding in patients with hemophilia B; Treat and prevent bleeding in patients with hemophilia B
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today